Rua Bioscience Limited (NZE: RUA)
New Zealand
· Delayed Price · Currency is NZD
0.0280
0.00 (0.00%)
Jan 7, 2025, 1:38 PM NZST
Rua Bioscience Balance Sheet
Financials in millions NZD. Fiscal year is July - June.
Millions NZD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 |
Cash & Equivalents | 0.9 | 0.9 | 2.53 | 1.9 | 3.36 | 3.94 | Upgrade
|
Short-Term Investments | - | - | 2.03 | 8.04 | 13.04 | - | Upgrade
|
Cash & Short-Term Investments | 0.9 | 0.9 | 4.56 | 9.94 | 16.4 | 3.94 | Upgrade
|
Cash Growth | -80.38% | -80.38% | -54.11% | -39.40% | 316.53% | -36.22% | Upgrade
|
Accounts Receivable | 0.03 | 0.03 | 0.1 | - | - | - | Upgrade
|
Other Receivables | 0.24 | 0.24 | 0.68 | 0.54 | 0.6 | 0.78 | Upgrade
|
Receivables | 0.26 | 0.26 | 0.78 | 0.54 | 0.6 | 0.78 | Upgrade
|
Inventory | 0.61 | 0.61 | 0.12 | 0.22 | - | - | Upgrade
|
Prepaid Expenses | 0.15 | 0.15 | 0.06 | 0.17 | 0.11 | 0.08 | Upgrade
|
Restricted Cash | - | - | - | 0.5 | - | - | Upgrade
|
Other Current Assets | 0.89 | 0.89 | 0.09 | 0.03 | 0 | 0.02 | Upgrade
|
Total Current Assets | 2.82 | 2.82 | 5.6 | 11.39 | 17.12 | 4.82 | Upgrade
|
Property, Plant & Equipment | 2.65 | 2.65 | 4.54 | 6.64 | 7.1 | 5.91 | Upgrade
|
Goodwill | 2.19 | 2.19 | 10.45 | 10.45 | 4 | 4 | Upgrade
|
Other Intangible Assets | - | - | 0.29 | 5.02 | - | - | Upgrade
|
Long-Term Deferred Tax Assets | - | - | - | - | 2.55 | 0.8 | Upgrade
|
Other Long-Term Assets | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.2 | Upgrade
|
Total Assets | 7.74 | 7.74 | 20.95 | 33.57 | 30.85 | 15.73 | Upgrade
|
Accounts Payable | 0.42 | 0.42 | 0.28 | 0.32 | 0.45 | 0.51 | Upgrade
|
Accrued Expenses | 0.31 | 0.31 | 0.24 | 0.46 | 0.52 | 0.25 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 0.01 | 0.08 | Upgrade
|
Current Portion of Leases | 0.05 | 0.05 | 0.05 | 0.13 | 0.13 | 0.07 | Upgrade
|
Current Unearned Revenue | 0.07 | 0.07 | 0.01 | 0.01 | - | 0.09 | Upgrade
|
Other Current Liabilities | 0.03 | 0.03 | 0.18 | 3.94 | 0.06 | - | Upgrade
|
Total Current Liabilities | 0.87 | 0.87 | 0.76 | 4.86 | 1.18 | 1 | Upgrade
|
Long-Term Debt | - | - | - | - | - | 0.01 | Upgrade
|
Long-Term Leases | 0.1 | 0.1 | 0.07 | 0.7 | 0.81 | 0.19 | Upgrade
|
Other Long-Term Liabilities | - | - | - | 3.82 | 0.03 | 0.12 | Upgrade
|
Total Liabilities | 0.97 | 0.97 | 0.83 | 9.38 | 2.02 | 1.33 | Upgrade
|
Common Stock | 43.95 | 43.95 | 43.7 | 41.89 | 37.42 | 18.92 | Upgrade
|
Retained Earnings | -37.51 | -37.51 | -23.79 | -17.84 | -9.2 | -4.78 | Upgrade
|
Comprehensive Income & Other | 0.33 | 0.33 | 0.21 | 0.14 | 0.61 | 0.26 | Upgrade
|
Shareholders' Equity | 6.77 | 6.77 | 20.12 | 24.2 | 28.83 | 14.4 | Upgrade
|
Total Liabilities & Equity | 7.74 | 7.74 | 20.95 | 33.57 | 30.85 | 15.73 | Upgrade
|
Total Debt | 0.15 | 0.15 | 0.11 | 0.82 | 0.95 | 0.35 | Upgrade
|
Net Cash (Debt) | 0.75 | 0.75 | 4.45 | 9.11 | 15.45 | 3.59 | Upgrade
|
Net Cash Growth | -83.19% | -83.19% | -51.21% | -40.99% | 330.41% | -39.75% | Upgrade
|
Net Cash Per Share | 0.00 | 0.00 | 0.03 | 0.06 | 0.12 | 0.04 | Upgrade
|
Filing Date Shares Outstanding | 159.75 | 159.75 | 158.14 | 149.88 | 140.26 | 100.01 | Upgrade
|
Total Common Shares Outstanding | 159.75 | 159.75 | 158.14 | 149.88 | 140.26 | 100.01 | Upgrade
|
Working Capital | 1.94 | 1.94 | 4.84 | 6.54 | 15.94 | 3.82 | Upgrade
|
Book Value Per Share | 0.04 | 0.04 | 0.13 | 0.16 | 0.21 | 0.14 | Upgrade
|
Tangible Book Value | 4.57 | 4.57 | 9.39 | 8.73 | 24.83 | 10.4 | Upgrade
|
Tangible Book Value Per Share | 0.03 | 0.03 | 0.06 | 0.06 | 0.18 | 0.10 | Upgrade
|
Buildings | 2.96 | 2.96 | 4.34 | 4.82 | 4.72 | 2.12 | Upgrade
|
Machinery | 1.58 | 1.58 | 1.85 | 2.27 | 1.88 | 1.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.